188 related articles for article (PubMed ID: 8531376)
1. [Sjögren's syndrome associated with non-Hodgkin's lymphoma].
Nagai K
Nihon Rinsho; 1995 Oct; 53(10):2574-9. PubMed ID: 8531376
[TBL] [Abstract][Full Text] [Related]
2. Differential risk of non-Hodgkin's lymphoma in Italian patients with primary Sjögren's syndrome.
Valesini G; Priori R; Bavoillot D; Osborn J; Danieli MG; Del Papa N; Gerli R; Pietrogrande M; Sabbadini MG; Silvestris F; Valsecchi L
J Rheumatol; 1997 Dec; 24(12):2376-80. PubMed ID: 9415645
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus study in malignant lymphoma in Sjögren's syndrome.
Hirose Y; Sugai S; Masaki Y; Ogawa Y; Takeshita S; Kin C; Ogawa N
Int J Hematol; 1999 Apr; 69(3):174-9. PubMed ID: 10222656
[TBL] [Abstract][Full Text] [Related]
4. Lymphoma development in Sjögren's syndrome: novel p53 mutations.
Tapinos NI; Polihronis M; Moutsopoulos HM
Arthritis Rheum; 1999 Jul; 42(7):1466-72. PubMed ID: 10403275
[TBL] [Abstract][Full Text] [Related]
5. Non-Hodgkin's lymphoma associated with primary Sjögren's syndrome.
Pariente D; Anaya JM; Combe B; Jorgensen C; Emberger JM; Rossi JF; Sany J
Eur J Med; 1992 Oct; 1(6):337-42. PubMed ID: 1341461
[TBL] [Abstract][Full Text] [Related]
6. [Characteristics of patients with primary Sjögren's syndrome and non-Hodgkin's lymphoma: analysis of 9 cases].
Jia N; Tang FL
Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(39):2786-8. PubMed ID: 20137605
[TBL] [Abstract][Full Text] [Related]
7. Sjögren's syndrome in patients with newly diagnosed untreated non-Hodgkin's lymphoma.
Andonopoulos AP; Tiniakou M; Melachrinou M; Sfountouris H; Bounas A; Zervas C; Zoumbos NC
Rev Rhum Engl Ed; 1997 May; 64(5):287-92. PubMed ID: 9190001
[TBL] [Abstract][Full Text] [Related]
8. Predicting the outcome of Sjogren's syndrome-associated non-hodgkin's lymphoma patients.
Papageorgiou A; Ziogas DC; Mavragani CP; Zintzaras E; Tzioufas AG; Moutsopoulos HM; Voulgarelis M
PLoS One; 2015; 10(2):e0116189. PubMed ID: 25723713
[TBL] [Abstract][Full Text] [Related]
9. Association between primary Sjögren's syndrome and non-Hodgkin's lymphoma.
Opriş D; Iosif CI; Predeţeanu D
Rom J Intern Med; 2004; 42(4):715-23. PubMed ID: 16366143
[TBL] [Abstract][Full Text] [Related]
10. Low miR200b-5p levels in minor salivary glands: a novel molecular marker predicting lymphoma development in patients with Sjögren's syndrome.
Kapsogeorgou EK; Papageorgiou A; Protogerou AD; Voulgarelis M; Tzioufas AG
Ann Rheum Dis; 2018 Aug; 77(8):1200-1207. PubMed ID: 29779010
[TBL] [Abstract][Full Text] [Related]
11. The P2X7 receptor-NLRP3 inflammasome complex predicts the development of non-Hodgkin's lymphoma in Sjogren's syndrome: a prospective, observational, single-centre study.
Baldini C; Santini E; Rossi C; Donati V; Solini A
J Intern Med; 2017 Aug; 282(2):175-186. PubMed ID: 28503820
[TBL] [Abstract][Full Text] [Related]
12. Cryoglobulinaemia related to Sjogren's syndrome or HCV infection: differences based on the pattern of bone marrow involvement, lymphoma evolution and laboratory tests after parotidectomy.
De Vita S; Quartuccio L; Salvin S; Corazza L; Zabotti A; Fabris M
Rheumatology (Oxford); 2012 Apr; 51(4):627-33. PubMed ID: 22210656
[TBL] [Abstract][Full Text] [Related]
13. Salivary gland lymphomas in patients with Sjögren's syndrome may frequently develop from rheumatoid factor B cells.
Martin T; Weber JC; Levallois H; Labouret N; Soley A; Koenig S; Korganow AS; Pasquali JL
Arthritis Rheum; 2000 Apr; 43(4):908-16. PubMed ID: 10765938
[TBL] [Abstract][Full Text] [Related]
14. [Lymphoproliferative disorders in patients with Sjögren's syndrome--Vg gene rearrangement and expression of bcl-2 protein].
Sugai S; Takeshita S; Ogawa Y; Masaki Y; Doumiki T; Takeuchi Y
Nihon Rinsho; 1995 Oct; 53(10):2580-6. PubMed ID: 8531377
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype.
Smedby KE; Hjalgrim H; Askling J; Chang ET; Gregersen H; Porwit-MacDonald A; Sundström C; Akerman M; Melbye M; Glimelius B; Adami HO
J Natl Cancer Inst; 2006 Jan; 98(1):51-60. PubMed ID: 16391371
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus infection, Sjögren's syndrome, and non-Hodgkin's lymphoma.
Selva-O'Callaghan A; Rodriguez-Pardo D; Sanchez-Sitjes L; Matas-Pericas L; Solans-Laque R; Bosch-Gil JA; Vilardell-Tarrés M
Arthritis Rheum; 1999 Nov; 42(11):2489-90. PubMed ID: 10555045
[No Abstract] [Full Text] [Related]
17. Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin's lymphoma: a case-control study.
Engels EA; Cerhan JR; Linet MS; Cozen W; Colt JS; Davis S; Gridley G; Severson RK; Hartge P
Am J Epidemiol; 2005 Dec; 162(12):1153-61. PubMed ID: 16251389
[TBL] [Abstract][Full Text] [Related]
18. [Sjögren's syndrome and non-Hodgkin's lymphoma: from pathophysiology to treatment].
Le Guern V; Mouthon L
Presse Med; 2011 Dec; 40(12 Pt 1):1113-9. PubMed ID: 21964038
[TBL] [Abstract][Full Text] [Related]
19. [Lymphoproliferative disorders in Sjögren's syndrome].
Prochorec-Sobieszek M; Wagner T
Otolaryngol Pol; 2005; 59(4):559-64. PubMed ID: 16273862
[TBL] [Abstract][Full Text] [Related]
20. The polymerase chain reaction detects B cell clonalities in patients with Sjögren's syndrome and suspected malignant lymphoma.
De Vita S; Ferraccioli G; De Re V; Dolcetti R; Carbone A; Bartoli E; Boiocchi M
J Rheumatol; 1994 Aug; 21(8):1497-501. PubMed ID: 7983653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
